Additionally, CD8+ T cells derived from SA-ESCC patients mainly belonged to phase 1 and phase 2, with only a few cells assigned to phase 3 (Fig. 8C, D). The gene discussed is CD8A; the disease is esophageal squamous cell carcinoma.